Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP285948.RAWo3Mra-fz7z2azZHW98L5UErkma4FEONkyRDkqH5a-k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP285948.RAWo3Mra-fz7z2azZHW98L5UErkma4FEONkyRDkqH5a-k130_assertion type Assertion NP285948.RAWo3Mra-fz7z2azZHW98L5UErkma4FEONkyRDkqH5a-k130_head.
- NP285948.RAWo3Mra-fz7z2azZHW98L5UErkma4FEONkyRDkqH5a-k130_assertion description "[Thus, this study has identified that carriers of HLA-DR16 are at high risk for CE, so appropriate preventive measures and quick and careful treatment should be applied to those patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP285948.RAWo3Mra-fz7z2azZHW98L5UErkma4FEONkyRDkqH5a-k130_provenance.
- NP285948.RAWo3Mra-fz7z2azZHW98L5UErkma4FEONkyRDkqH5a-k130_assertion evidence source_evidence_literature NP285948.RAWo3Mra-fz7z2azZHW98L5UErkma4FEONkyRDkqH5a-k130_provenance.
- NP285948.RAWo3Mra-fz7z2azZHW98L5UErkma4FEONkyRDkqH5a-k130_assertion SIO_000772 20424860 NP285948.RAWo3Mra-fz7z2azZHW98L5UErkma4FEONkyRDkqH5a-k130_provenance.
- NP285948.RAWo3Mra-fz7z2azZHW98L5UErkma4FEONkyRDkqH5a-k130_assertion wasDerivedFrom befree-20140225 NP285948.RAWo3Mra-fz7z2azZHW98L5UErkma4FEONkyRDkqH5a-k130_provenance.
- NP285948.RAWo3Mra-fz7z2azZHW98L5UErkma4FEONkyRDkqH5a-k130_assertion wasGeneratedBy ECO_0000203 NP285948.RAWo3Mra-fz7z2azZHW98L5UErkma4FEONkyRDkqH5a-k130_provenance.